Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-18

Clinical Trial Update: A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a fish oil supplement to maintain body weight in patients with cancer-related weight loss (cancer cachexia) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fish oil supplement (fish oil)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Cancer, Cancer Cachexia | Phase 2 | Status: COMPLETED